Maximus (NYSE:MMS) Issues FY 2025 Earnings Guidance

Maximus (NYSE:MMS) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share guidance of 5.900-6.200 for the period, compared to the consensus earnings per share estimate of 5.950. The company issued revenue guidance of $5.2 billion-$5.4 billion, compared to the consensus revenue estimate of $5.3 billion.

Maximus Stock Down 0.2 %

Shares of MMS traded down $0.13 during trading hours on Friday, reaching $69.87. The stock had a trading volume of 639,934 shares, compared to its average volume of 698,265. The firm has a 50-day simple moving average of $74.83 and a 200 day simple moving average of $83.53. Maximus has a 12 month low of $68.30 and a 12 month high of $93.97. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.59. The company has a market capitalization of $3.99 billion, a price-to-earnings ratio of 13.96 and a beta of 0.72.

Maximus (NYSE:MMS) last released its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, beating analysts’ consensus estimates of $1.39 by $0.22. Maximus had a net margin of 5.78% and a return on equity of 20.95%. Equities research analysts predict that Maximus will post 5.95 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Saturday, February 15th will be issued a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.72%. Maximus’s dividend payout ratio is presently 24.00%.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a report on Thursday. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a report on Thursday, January 2nd.

Insider Transactions at Maximus

In related news, CEO Bruce Caswell acquired 3,500 shares of the firm’s stock in a transaction that occurred on Tuesday, December 17th. The stock was acquired at an average price of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the acquisition, the chief executive officer now owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. This represents a 1.28 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Raymond B. Ruddy acquired 3,490 shares of the stock in a transaction on Thursday, December 12th. The stock was bought at an average cost of $71.46 per share, for a total transaction of $249,395.40. Following the transaction, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their position. The disclosure for this purchase can be found here. Insiders have acquired 7,063 shares of company stock worth $502,017 in the last 90 days. Insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.